Netherlands· NL-07e7ac011e77

Letrozol Sandoz 2,5 mg, filmomhulde tabletten

A letrozole product containing letrozol, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 18 of our 19 countries.

ATC L02BG04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about letrozolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Letrozole is registered in 18 of 19 countries.

Countries holding a registration under ATC L02BG04 (letrozole), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search letrozole products by name

Letrozole · ATC L02BG04

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of letrozole costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $1.23 in France to $27.12 in United States — a ×22 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Letrozole · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

US United States$27.12 (acquisition cost)
CH Switzerland$2.73
IT Italy$2.51
FR France$1.23

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: LETROZOL
Manufacturer: Sandoz B.V.
Country: Netherlands (NL)
ATC code: L02BG04
ATC class: Letrozole
Defined daily dose: 2.5 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
106323

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

311 interactions on record for letrozole.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check letrozole against other medicines How interaction checks work

Letrozole · interactions on record

311 records

2 severe
93 moderate
7 minor
209 info

Most severe, free to view

ThalidomideL04AX02severe
CitalopramN06AB04severe
AprepitantA04AD12moderate
LonafarnibA16AX20moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Letrozole in 18 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All letrozole products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Femara, Letrofam
Belgium · Femara, Letrozol Sandoz
Bulgaria · Етрузил, Зеквипра
Cyprus · Femara, Feremazol
Czechia · Aletro, Dracenax
Germany · Femara, Letro-Cell
Denmark · Letrozol Accord, Letrozol Medical Valley
Estonia · Femara, Feremazol
Spain · Femara, Galdar
Finland · Femar, Letrolan
France · Femara, Letrozole Accord Healthcare
United Kingdom (Northern Ireland) · Femara, Letrozole
Greece · Femaplex, Femara
Croatia · Avomit, Femara
Hungary · Etruzil, Famos
Ireland · Femara, Letrozole Accord Healthcare Ireland
Iceland · Letromal, Letrozol Actavis
Italy · Blormat, Brestoral
Lithuania · Femara, Feremazol
Luxembourg · Femara, Letrozole Eg
Latvia · Femara, Letrozole Sanoswiss
Malta · Femara, Feremazol
Norway · Femar, Letrozol Accord
Poland · Aromek, Clarzole
Portugal · Femara, Letrozol Accord
Romania · Elozora, Etruzil
Sweden · Letrozol Accord, Letrozol Medical Valley
Slovenia · Femara, Letrozol Genthon
Slovakia · Aletro, Etruzil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f376064e-0cb6-417d-847e-b5640748758c
GET /v1/drugs/f376064e-0cb6-417d-847e-b5640748758c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h106323_smpc_en.pdf",
  "strength": null,
  "atc_label": "Letrozole",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg106323",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "NATRIUMZETMEELGLYCOLAAT",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "LETROZOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h106323_piluk.pdf",
  "authorised_at": "2010/11/02",
  "procedure_number": "NL/H/1814/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "106323",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about letrozole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console